Инструкция по применению IMMUBRON
Содержание инструкции
IMMUBRON 50 mg sublingual tablets
Read this leaflet carefully before taking this medicine as it contains important
information for you.
- Keep this leaflet. You may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
- If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
Contents of this leaflet:
- 1. What IMMUBRON is and what it is used for
- 2. What you need to know before you take IMMUBRON
- 3. How to take IMMUBRON
- 4. Possible side effects
- 5. How to store IMMUBRON
- 6. Contents of the pack and other information
1. What is IMMUBRON and what is it used for
IMMUBRON contains as its active ingredient a mixture of lyophilized bacterial lysates (bacterial antigens),
belonging to the group of bacterial vaccines, which locally stimulate the activity of the body's defense
system (immune system).
IMMUBRON is indicated for the prophylaxis of recurrent respiratory tract infections in adults.
2. What you need to know before you take IMMUBRON
Do not take IMMUBRON
- if you are allergic to the active ingredients or to any of the other ingredients of this medicine (listed in section 6);
- if you suffer from diseases of the immune system (autoimmune diseases);
- if you have developed an intestinal infection (acute intestinal infections).
Warnings and precautions
Consult your doctor or pharmacist before taking IMMUBRON.
Take this medicine with caution and inform your doctor if you suffer from any form of allergy.
Stop treatment and consult your doctor, who will assess whether to discontinue therapy with
IMMUBRON permanently, if you experience the following conditions:
- allergic reactions (hypersensitivity reactions);
- asthma attacks in predisposed patients;
- fever, especially if it occurs at the beginning of treatment; The type of high fever above 39°C that may occur as a rare, isolated and of unknown cause adverse event, must be differentiated from the fever that occurs following the original pathology, based on the laryngeal, nasal or otological conditions.
The use of IMMUBRON for the prevention of pneumonia is not recommended because there is no data
from clinical studies demonstrating such an effect.
Other medicines and IMMUBRON
Tell your doctor or pharmacist if you are taking, have recently taken or might take any
other medicine.
Avoid taking IMMUBRON together with other medicines that stimulate the activity of the immune
system (immunostimulants).
Immubron may be less effective if you suffer from disorders of the immune system (with congenital or acquired
immunodeficiency), if you are following a therapy with medicines that reduce the activity of the immune
system (immunosuppressive therapy) or if you are taking medicines used for the treatment of
allergies and inflammation (corticosteroids).
Interaction studies with other drugs or vaccines have not been conducted.
Immubron with food and drink
The medicine must be taken on an empty stomach
Pregnancy and breastfeeding
Do not take IMMUBRON if you are pregnant.
Do not take IMMUBRON if you are breastfeeding.
Driving and operating machinery
No effects on the ability to drive vehicles or operate machinery have been reported and no
specific studies have been conducted.
3. How to take IMMUBRON
Take this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, consult your doctor or pharmacist.
The recommended dose is 1 tablet a day, to be dissolved under the tongue.
The treatment involves administering 1 tablet for 10 consecutive days a month, for a duration of
3 months.
If you take more IMMUBRON than you should
No cases of overdose are known.
In case of accidental intake/ingestion of an excessive dose of IMMUBRON, immediately
inform your doctor or go to the nearest hospital.
If you forget to take IMMUBRON
Do not take a double dose to make up for the missed tablet.
If you have any doubts about the use of this medicine, consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur:
Frequency not known(the frequency of which cannot be estimated from available data)
- pain in the mouth and pharynx (oropharyngeal pain);
- allergic skin reactions (urticaria, rash, itching, edema);
- fever and headache;
- stomach pain and vomiting;
- inflammation of the nasal mucosa (rhinitis).
Reporting of side effects
If you get any side effects, even those not listed in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store IMMUBRON
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after “Scad.”. The expiry date refers to the last day of that month and the product in intact packaging, correctly
stored.
Do not store at a temperature above 25°C.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to dispose of
medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What IMMUBRON contains
- The active ingredient is a lyophilized bacterial lysate 50 mg, of which 7 mg corresponds to: Staphylococcus aureus 6 billion - Streptococcus pyogenes 6 billion - Streptococcus oralis 6 billion - Klebsiella pneumoniae 6 billion - Klebsiella ozaenae 6 billion - Haemophilus influenzae serotype B 6 billion - Neisseria catarrhalis 6 billion - Streptococcus pneumoniae 6 billion (of which type TY1/EQ11 1 billion
- TY2/EQ22 1 billion - TY3/EQ14 1 billion - TY5/EQ15 1 billion - TY8/EQ23 1 billion - TY47/EQ24 1 billion) and 43 mg of lyophilizate support glycocolla.
- The other components are: silicon dioxide, microcrystalline cellulose, dibasic calcium phosphate, magnesium stearate, ammonium glycyrrhizinate, powdered mint essence.
Description of the appearance of IMMUBRON and contents of the pack
Pack containing 30 sublingual tablets of 50 mg.
Marketing authorization holder and manufacturer
Bruschettini s.r.l. – Via Isonzo, 6 – 16147 Genova – Italia

- Страна регистрации
- Форма выпускаTablet, 50 MG
- Отпускается по рецептуНет
- Производитель
- Информация на этой странице носит справочный характер и не является медицинской консультацией. Перед началом приема лекарства обязательно проконсультируйтесь с врачом.
- Аналоги IMMUBRONФорма выпуска: Powder and solvent for injectable solution, 0,5 MLДействующее вещество: haemophilus influenzae B, combinations with toxoidsПроизводитель: SANOFI WINTHROP INDUSTRIEОтпускается по рецептуФорма выпуска: Injectable suspension in pre-filled syringe, 0.5MLДействующее вещество: meningococcus B, multicomponent vaccineПроизводитель: GLAXOSMITHKLINE VACCINES S.R.L.Отпускается без рецептаФорма выпуска: Injectable suspension, 0.5 MLДействующее вещество: pertussis, purified antigen, combinations with toxoidsПроизводитель: GLAXOSMITHKLINE S.P.A.Отпускается без рецепта
Аналоги IMMUBRON в других странах
Лекарства с тем же действующим веществом, доступные в других странах.
Аналог IMMUBRON в Польша
Аналог IMMUBRON в Украина
Врачи онлайн по IMMUBRON
Обсудите применение IMMUBRON и возможные следующие шаги — по оценке врача.
Получите рецепт на IMMUBRON онлайн
Заполните форму за 2 минуты
Расскажите о симптомах, истории болезни и нужном препарате.
Выберите врача или мы назначим
Выберите специалиста или мы подберём ближайшего доступного врача.
Врач рассматривает ваш случай
Обычно в течение 30 минут. Может задать уточняющие вопросы в чате.
Получите в любой аптеке
Электронный рецепт отправляется на вашу почту — действителен по всей Польше.
Часто задаваемые вопросы
IMMUBRON не требует рецепта в Италия. Вы можете уточнить у врача онлайн, подходит ли это лекарство для вашей ситуации.
IMMUBRON производится компанией BRUSCHETTINI S.R.L.. Упаковка и торговое название могут отличаться в зависимости от дистрибьютора.
Врачи, включая Семейные врачи, Психиатры, Дерматологи, Кардиологи, Эндокринологи, Гастроэнтерологи, Пульмонологи, Нефрологи, Ревматологи, Гематологи, Инфекционисты, Аллергологи, Гериатры, Педиатры, Онкологи, могут оценить целесообразность применения IMMUBRON с учетом вашей ситуации и местных правил. Вы можете записаться на онлайн-консультацию, чтобы обсудить возможные варианты.
Польша имеет хорошо развитую систему здравоохранения в крупных городах, таких как Варшава, Краков, Вроцлав и Гданьск. Аптеки широко доступны и работают в соответствии с действующим законодательством, обеспечивая доступ к рецептурным препаратам.
Вы можете купить IMMUBRON в Варшаве, Кракове, Вроцлаве или Гданьске в любой аптеке при наличии действующего рецепта.
Чтобы получить рецепт, вы можете воспользоваться Oladoctor:
Другие лекарства с тем же действующим веществом () включают AKTIB, BEXSERO, BOOSTRIX. Они могут отличаться торговым названием или формой выпуска, но содержат одинаковый терапевтический компонент. Перед изменением лечения рекомендуется проконсультироваться с врачом.
















